Measles Antibody in CSF for SSPE Diagnosis

Diagnostic Value of Measles Antibodies in CSF for SSPE

Detection of intrathecal synthesis of measles-specific antibodies in CSF is a crucial diagnostic criterion for SSPE, characterized by insidious onset, subtle personality changes, declining intellectual performance progressing to mental deterioration, seizures, myoclonic jerks, motor signs, coma, and death 1, 2
The EEG in SSPE reveals well-defined periodic complexes with a 1:1 relationship with the myoclonic jerks, which is another distinctive feature 1
Measles can cause three separate encephalitic illnesses: acute encephalitis or acute disseminated encephalomyelitis associated with acute infection, subacute encephalopathy in immunocompromised patients, and SSPE in immunologically normal individuals 2, 3

The detection of measles antibodies in CSF should be interpreted in the context of clinical presentation, EEG findings, and history of measles infection or vaccination status 1

Consider PCR testing of CSF for measles virus RNA, though antibody testing is often more reliable for SSPE 1
Look for oligoclonal bands in CSF with immunoblotting against measles virus proteins 4

The MRZ reaction can be present in multiple sclerosis, potentially causing confusion, but the pattern differs from the isolated strong measles response in SSPE 5

Intrathecal ribavirin has been used for treatment of SSPE, though with limited success 1

The Centers for Disease Control and Prevention recommends that measles vaccination is the only effective prevention strategy for SSPE, which has led to near elimination of cases in countries with high vaccination coverage, and the administration of live measles vaccine does not increase the risk for SSPE 6, 7, 8, 9
The disease is caused by persistent measles virus infection, not by measles vaccination—vaccination actually prevents SSPE, and evidence indicates that children who developed SSPE after vaccination likely had unrecognized measles infection before vaccination 6, 7, 8, 9

The ACIP definitively states that MMR vaccine does not increase the risk for SSPE, regardless of whether the vaccinee has had measles infection or has previously received live measles vaccine, as supported by the Advisory Committee on Immunization Practices 10, 11, 12
The Centers for Disease Control and Prevention, as reflected in the MMWR Recommendations and Reports, notes that when rare SSPE cases have been reported in vaccinated children without known measles history, evidence indicates these children likely had unrecognized measles infection before vaccination, and the SSPE resulted from that natural infection, not the vaccine 10, 11, 12

The ACIP advises not to confuse SSPE with acute post-vaccination encephalopathy, which if it were to occur (extremely rare at approximately 1 per 2 million doses), would present around 10 days after vaccination, not one year later, according to the Advisory Committee on Immunization Practices 12
The CDC recommends not to confuse SSPE with febrile seizures, which occur 5-12 days after MMR vaccination at a rate of approximately 1 per 3,000 doses and do not lead to residual neurologic disorders, as stated in the MMWR Recommendations and Reports 10, 12

At one year after MMR vaccination, a child would be beyond the window for vaccine-related adverse events (which cluster in the first 2-3 weeks), as reported by the Advisory Committee on Immunization Practices 11

In acute measles infection, IgM antibodies appear at or shortly after rash onset, peak around 10 days after rash, and become undetectable within 30-60 days after rash onset, according to the Centers for Disease Control and Prevention 13

The American Academy of Pediatrics and the Centers for Disease Control and Prevention recommend that diagnosis of SSPE should not rely on IgM testing, but rather on elevated measles IgG titers in CSF, characteristic EEG findings, and compatible clinical presentation, with a strength of evidence based on expert opinion 13